Principle mechanisms underlying venous thromboembolism: Epidemiology, risk factors, pathophysiology and pathogenesis

Respiration

Volumn 70, Issue 1, 2003, Pages 7-30

  Kroegel, Claus ^a   Reissig, Angelika ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

Deep vein thrombosis; Etiology; Inflammation; Pathogenesis; Pathophysiology; Pulmonary embolism; Risk factors; Thrombophilia; Venous thromboembolism

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN; ORAL CONTRACEPTIVE AGENT; PROTEIN C; PROTEIN S;

AGING; AUTOPSY; BLOOD VESSEL INJURY; CANCER; CLINICAL EXAMINATION; COMORBIDITY; CYTOKINE RELEASE; DEEP VEIN THROMBOSIS; DISEASE PREDISPOSITION; DYSPNEA; GASTROCNEMIUS MUSCLE; GENETIC RISK; HEMOPTYSIS; HORMONE SUBSTITUTION; HOSPITALIZATION; HUMAN; HYPERCOAGULABILITY; IMMOBILIZATION; INJURY; LUNG EMBOLISM; MORTALITY; NEUROLOGIC DISEASE; PARESIS; PATHOGENESIS; PATHOPHYSIOLOGY; PELVIS; PNEUMONIA; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROTEIN DEFICIENCY; REVIEW; RISK FACTOR; SHOCK; SYMPTOM; THORAX PAIN; THROMBOEMBOLISM; VEIN; VENOUS STASIS;

COMORBIDITY; CYTOKINES; HUMANS; PULMONARY EMBOLISM; RISK FACTORS; TIME FACTORS; VENOUS THROMBOSIS;

EID: 0037275643     PISSN: 00257931     EISSN: None     Source Type: Journal    
DOI: 10.1159/000068427     Document Type: Review

References (172)

1. Goldhaber SZ: Pulmonary embolism. N Engl J Med 1998;339:93-104.
2. Siddique RM, Siddique MI, Rimm AA: Trends in pulmonary embolism mortality in the US elderly population: 1984 through 1991. Am J Public Health 1998;88:478-480.
3. D'Angelo E: Advance in basic laboratory and clinical aspects of thromboembolic diseases: Lung mechanics and gas exchange in pulmonary embolism. Haematologica 1997;82:371-374.
4. Perrier A: Noninvasive diagnosis of pulmonary embolism. Haematologica 1997;82:328-331.
5. Anderson FA Jr, Wheeler HB, Goldberg RJ, Hosmer DW, Patwardhan NA, Jovanovic B, Forcier A, Dalen JE: A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study. Arch Intern Med 1991;151:933-938.
6. Dalen JE, Alpert JS: Natural history of pulmonary embolism. Prog Cardiovasc Dis 1975;17:257-270.
7. Clagett GP, Anderson FA Jr, Heit J, et al: Prevention of venous thromboembolism. Chest 1995;108(suppl):312S-334S.
8. Garg K: CT of pulmonary thromboembolic disease. Radiol Clin North Am 2002;40:111-122.
9. Gray HW: The natural history of venous thromboembolism: Impact on ventilation/perfusion scan reporting. Semin Nucl Med 2002;32:159-172.
10. Atrash HK, Koonin LM, Lawson HW, Franks AL, Smith JC: Maternal mortality in the United States, 1979-1986. Obstet Gynecol 1990;76:1055-1060.
11. Dalen JE: Pulmonary embolism: What have we learned since Virchow?: Treatment and prevention. Chest 2002;122:1801-1817.
12. Heit JA: Venous thromboembolism epidemiology: Implications for prevention and management. Semin Thromb Hemost 2002;28(suppl 2):3-14.
13. Nordstrom M, Lindblad B: Autopsy-verified venous thromboembolism within a defined urban population: The city of Malmö, Sweden. APMIS 1998;106:378-384.
14. Coon WW, Coller FA: Clinicopathologic correlation in thromboembolism. Surg Gynecol Obstet 1959;109:259-269.
15. Morrell MT, Dunnill MS: The post-mortem incidence of pulmonary embolism in a hospital population. Br J Surg 1968;55:347-352.
16. Goldhaber SZ, Hennekens CH, Evans DA, Newton EC, Godleski JJ: Factors associated with correct ante-mortem diagnosis of major pulmonary embolism. Am J Med 1982;73:822-826.
17. Stein PD, Henry JW: Prevalence of acute pulmonary embolism among patients in a general hospital and at autopsy. Chest 1995;108:978-981.
18. The Columbus Investigators: Low-molecular-weight heparin in the treatment of patients with venous thromboembolism. N Engl J Med 1997;337:657-662.
19. Simonneau G, Sors H, Charbonnier B, et al: A comparison of low-molecular-weight heparin with unfractionated heparin for acute pulmonary embolism: The THESEE Study Group; Tinzaparine ou Héparine Standard - Evaluations dans l'Embolie Pulmonaire. N Engl J Med 1997;337:663-669.
20. Goldhaber SZ, Visani L, De Rosa M: Acute pulmonary embolism: Clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER). Lancet 1999;353:1386-1389.
21. Kasper W, Konstantinides S, Geibel A, et al: Management strategies and determinants of outcome in acute major pulmonary embolism: Results of a multicenter registry. J Am Coll Cardiol 1997;30:1165-1171.
22. Secker-Walker RH, Jackson JA, Goodwin J: Resolution of pulmonary embolism. Br Med J 1970;4:135-141.
23. Winebright JW, Gerdes AJ, Nelp WB: Restoration of blood flow after pulmonary embolism. Arch Intern Med 1970;125:241-247.
24. Austin JHW, Wilner GD, Dominguez C: Natural history of pulmonary thromboemboli in dogs: Serial radiographic observations of clots labeled with powdered tantalum. Radiology 1975;116:519-527.
25. Moser KM, Guisan M, Bartimmo EE, Longo AM, Harsanyi PG, Chiorazzi N: In vivo and post mortem dissolution rates of pulmonary emboli and venous thrombi in the dog. Circulation 1973;48:170-178.
26. Moser KM, LeMoine JR: Is embolic risk conditioned by location of deep venous thrombosis? Ann Intern Med 1981;94:439-444.
27. Miller GA, Sutton GC: Acute massive pulmonary embolism: Clinical and haemodynamic findings in 23 patients studied by cardiac catheterization and pulmonary arteriography. Br Heart J 1970;32:518-523.
28. Gorham LW: A study of pulmonary embolism: To the mechanism of death based on a clinical pathological investigation of 100 cases of massive and 285 cases of minor embolism of the pulmonary artery. Arch Intern Med 1961;108:76-90.
29. Del Guercio LRM, Cohn JDFNR: Pulmonary embolism shock: Physiologic basis of a bedside screening test. JAMA 1960;196:751-756.
30. McDonald IG, Hirsh J, Hale GS, et al: Major pulmonary embolism, a correlation of clinical findings, haemodynamics, pulmonary angiography, and pathological physiology. Br Heart J 1972;34:356-364.
31. Alderson PO, Dzebolo NN, Biello DR, et al: Serial lung scintigraphy: Utility in diagnosis of pulmonary embolism. Radiology 1983;149:797-804.
32. Tow DE, Wagner NH Jr: Recovery of pulmonary arterial blood flow in patients with pulmonary embolism. N Engl J Med 1967;276:1053-1059.
33. Hampton AO, Castleman B: Correlation of postmortem chest teleroentgenograms with autopsy findings. Am J Roentgenol Radium Ther 1940;43:305-326.
34. Simon M: Plain film and angiographic aspect of pulmonary embolism; in Moser K, Stein M (eds): Pulmonary Thromboembolism. Chicago, Yearbook Medical Publishers, 1973.
35. Urokinase Pulmonary Embolism Trial (UPET): Phase 1 results: A cooperative study. JAMA 1970;214:2163-2172.
36. Hoagland PM: Massive pulmonary embolism: Pulmonary embolism and deep vein thrombosis. Philadelphia, Saunders, 1985, pp 179-208.
37. Morgenthaler T, Ryu J: Clinical characteristics of fatal pulmonary embolism in a referral hospital. Mayo Clin Proc 1995;70:417-424.
38. Morpurgo M, Rustici A: The clinical picture of pulmonary embolism. Cardiologia 1988;33:1105-1108.
39. Morpurgo M, Schmid C: The spectrum of pulmonary embolism. Clinicopathologic correlations. Chest 1995;107(suppl):18S-20S.
40. Alpert JS, Smith R, Carlson J, et al: Mortality in patients treated for pulmonary embolism. JAMA 1976;236:1477-1480.
41. McIntyre KM, Sasahara AA: The hemodynamic response to pulmonary embolism in patients without prior cardiopulmonary disease. Am J Cardiol 1971;28:288-294.
42. McIntyre KM, Sasahara AA: Hemodynamic and ventricular responses to pulmonary embolism. Prog Cardiovasc Dis 1974A;17:175-190.
43. Heit JA, Silverstein MD, Mohr DN, Petterson TM, Lohse CM, O'Fallon WM, Melton LJ 3rd: The epidemiology of venous thromboembolism in the community. Thromb Haemost 2001;86:452-463.
44. Carson JL, Kelley MA, Duff A, et al: The clinical course of pulmonary embolism: One-year follow-up of PIOPED patients. N Engl J Med 1992;326:1240-1245.
45. Moser KM: Venous thromboembolism. Am Rev Respir Dis 1990;141:235-249.
46. Tapson VF, Witty LA: Massive pulmonary embolism. Diagnostic and therapeutic strategies. Clin Chest Med 1995;16:329-340.
47. Towbin A: Pulmonary embolism: Incidence and significance. JAMA 1954;156:209-215.
48. Pineda LA, Hathwar VS, Grant BJB: Clinical suspicion of fatal pulmonary embolism. Chest 2001;120:791-795.
49. Trousseau A: Phlegmasia alba colens. Clinique Médicale de l'Hôtel-Dieu de Paris, the New Sydennam Society, London 1865;3:94-111.
50. Sorensen HT, Mellemkjaer L, Steffensen FH, et al: The risk of a diagnosis of cancer after primary deep venous thrombosis or pulmonary embolism. N Engl J Med 1998;338:1169-1173.
51. Sorensen HT, Mellemkjaer L, Olsen JH, Baron JA: Prognosis of cancers associated with venous thromboembolism. N Engl J Med 2000;343:1846-1850.
52. Bauer KA: Venous thromboembolism in malignancy. J Clin Oncol 2000;18:3065.
53. Prandoni P, Lensing AWA, Buller HR, et al: Deep-vein thrombosis and the incidence of subsequent symptomatic cancer. N Engl J Med 1992;327:1128-1133.
54. Gerhardt A, Scharf RE, Beckmann MW, Struve S, Bender HG, Pillny M, Sandmann W, Zotz RB: Prothrombin and factor V mutations in women with a history of thrombosis during pregnancy and the puerperium. N Engl J Med 2000;342:374-380.
55. Virchow RLK: Gesammelte Abhandlungen zur wissenschaftlichen Medizin. Frankfurt, Meidinger, 1856, pp 285-294-296.
56. White RH, Romano PS, Zhou H, et al: Incidence and time course of thromboembolic outcomes following total hip or knee arthroplasty. Arch Intern Med 1998;158:1525-1531.
57. Bergqvist D, Benoni G, Bjorgell O, Fredin H, Hedlundh U, Nicolas S, Nilsson P, Nylander G: Low-molecular-weight heparin (enoxaparin) as prophylaxis against venous thromboembolism after total hip replacement. N Engl J Med 1996;335:696-700.
58. Kistner RL, Ball JJ, Nordyke RA, Freeman GC: Incidence of pulmonary embolism in the course of thrombophlebitis of the lower extremities. Am J Surg 1972;124:169-176.
59. Weinmann EE, Salzman EW: Deep-vein thrombosis. N Engl J Med 1994;331:1630-1641.
60. Furie B, Furie BC: Molecular and cellular biology of blood coagulation. N Engl J Med 1992;326:800-806.
61. Neumann FJ, Ott I, Marx N, et al: Effect of human recombinant interleukin-6 and interleukin-8 on monocyte procoagulant activity. Arterioscler Thromb Vasc Biol 1997;17:3399-3405.
62. van den Eijnden MM, Steenhauer SI, Reitsma PH, et al: Tissue factor expression during monocyte-macrophage differentiation. Thromb Haemost 1997;77:1129-1136.
63. Yamamoto M, Nakagaki T, Kisiel W: Tissue factor-dependent autoactivation of human blood coagulation factor. J Biol Chem 1992;267:19089-19094.
64. Gailani D, Broze GJ Jr: Factor XI activation by thrombin and factor XIa. Semin Thromb Hemost 1993;19:396-404.
65. Thompson CA, Skelton TN: Thromboembolism in the right side of the heart. South Med J 1999;92:826-830.
66. Casazza F, Bongarzoni A, Centonze F, et al: Prevalence and prognostic significance of right-sided cardiac mobile thrombi in acute massive pulmonary embolism. Am J Cardiol 1997;79:1433-1435.
67. Chernick V, Hodson WH, Greenfield LJ: Effects of chronic pulmonary artery ligation on pulmonary mechanisms and surfactant. J Appl Physiol 1966;21:1315-1320.
68. Kronik G: The European Cooperative Study on the clinical significance of right heart thrombi: European Working Group on Echocardiography. Eur Heart J 1989;10:1046-1059.
69. Wittlich N, Erbel R, Eichler A, et al: Detection of central pulmonary thromboemboli by transesophageal echocardiography in patients with severe pulmonary embolism. J Am Soc Echocardiogr 1992;5:515-524.
70. Farfel Z, Shechter M, Vered Z, et al: Review of echocardiographically diagnosed right heart entrapment of pulmonary emboli-in-transit with emphasis on management. Am Heart J 1987;113:171-178.
71. Krivec, B, Voga, G, Zuran, I, et al: Diagnosis and treatment of shock due to massive pulmonary embolism. Chest 1997;112:1310-1316.
72. Morgenstern E, Korell U, Richter J: Platelets and fibrin strands during clot retraction. Thromb Res 1984;33:617-623.
73. Sabovic M, Lijnen HR, Keber D, et al: Correlation between progressive adsorption of plasminogen to blood clots and their sensitivity to lysis. Thromb Haemost 1990;64:450-454.
74. Lin PH, Chen C, Sourowiec SM, et al: Evaluation of thrombolysis in a porcine model of chronic deep venous thrombosis: An endovascular model. J Vasc Surg 2001;33:621-627.
75. O'Shaughnessy AM, Fitzgerald DE: Determining the stage of organisation and natural history of thrombosis using computer analysis. Int Angiol 2000;19:220-227.
76. Chan RK, Johns JA, Calafiore P: Clinical implications of the morphological features of central pulmonary artery thromboemboli shown by transoesophageal echocardiography. Br Heart J 1994;72:58-62.
77. Karsner HT, Ash JE: Studies in infarctions. I. Experimental bland infarction of the lung. J Med Res 1912/1913;27:205-211.
78. Chapman DW, Gugle LJ, Wheeler PW: Experimental pulmonary infarction: Abnormal pulmonary circulation is a prerequisite for pulmonary infarction following an embolus. Arch Intern Med 1949;83:158-163.
79. Dalen JE, Haffajee CI, Alpert JS, et al: Pulmonary embolism, pulmonary hemorrhage and pulmonary infarction. N Engl J Med 1977;296:1431-14340.
80. Clark SW, Graf PD, Madel JA: In vivo visualisation of small airway constriction after pulmonary microembolism in cats and dogs. J Appl Physiol 1970;29:646-650.
81. Nadel JA, Colebatch HJH, Olsen CR: Location and mechanism of airway constriction after sulfate microembolism. J Appl Physiol 1964;19:387-394.
82. Lindquist O, Saldeen T, Sandler H: Pulmonary damage following pulmonary microembolism in the dog. Effect of various types of treatment. Acta Chir Scand 1976;142:15-19.
83. Nakos, G, Kitsiouli, EI, Lekka, ME: Bronchoalveolar lavage alterations in pulmonary embolism. Am J Respir Crit Care Med 1998;158:1504-1510.
84. Reeves WC, Demers LM, Wood MA, Skarlatos S, Copenhaver G, Whitesell L, Luderer JR: The release of thromboxane A2 and prostacyclin following experimental acute pulmonary embolism. Prostaglandins Leukot Med 1983;11:1-10.
85. Frazer RG, Paré JAP, Paré PD, Frazer RS, Genereux GP: Embolic and thrombotic diseases of the lung; in Frazer RG, Paré JAP, Paré PD, Frazer RS, Genereux GP (eds): Diagnosis of diseases of the chest, ed 3. Philadelphia, Saunders, 1990, pp 1701-1813.
86. Remy-Jardin M, Remy J, Deschildre F, et al: Diagnosis of pulmonary embolism with spiral CT: Comparison with pulmonary angiography and scintigraphy. Radiology 1996;200:699-706.
87. Stern EJ, Müller NL, Swensen SJ, Hartman TE: CT mosaic pattern of lung attenuation: Etiologies and terminology. J Thorac Imaging 1995;10:294-297.
88. Malik AB, Van der Zee H: Mechanism of pulmonary edema induced by microembolization in dogs. Circ Res 1978;42:72-79.
89. Ohkuda K, Nakahara K, Weidner WJ: Lung fluid exchange after uneven pulmonary artery obstruction in sheeps. Circ Res 1978;43:152-161.
90. Bergin CJ, Rios G, King MA, Belezzuoli E, Luna J, Auger WR: Accuracy of high-resolution CT in identifying chronic pulmonary thromboembolic disease. AJR 1996;166:1371-1377.
91. Roberts HC, Kauczor HU, Schweden F, Thelen M: Spiral CT of pulmonary hypertension and chronic thrombembolism. J Thorac Imaging 1997;12:118-127.
92. Schwickert HC, Schweden F, Schild HH, Piepenburg R, Duber C, Kauczor HU, Renner C, Iversen S, Thelen M: Pulmonary arteries and lung parenchyma in chronic pulmonary embolism: Preoperative and postoperative CT findings. Radiology 1994;191:351-357.
93. King MA, Bergin CJ, Yeung DWC, et al: Chronic pulmonary thromboembolism: Detection of regional hypoperfusion with CT. Radiology 1994;191:359-363.
94. Primack SL, Múller NL, Mayo JR, Remy-Jardin M, Remy J: Pulmonary parenchymal abnormalities of vascular origin: High-resolution CT findings. RadioGraphics 1994;14:739-746.
95. Levinson RM, Shure D, Moser KM: Reperfusion pulmonary edema after pulmonary artery thromboendarterectomy. Am Rev Respir Dis 1986;134:1241-1245.
96. Miller WT Jr, Osiason AW, Langlotz CP, Palevsky HI: Reperfusion pulmonary edema after thromboendarterectomy: Radiographic patterns of disease. J Thorac Imaging 1998;13:178-183.
97. Moser KM, Daily PO, Peterson K, et al: Thromboendarterectomy for chronic, major-vessel thromboembolic pulmonary hypertension: Immediate and long-term results in 42 patients. Ann Intern Med 1987;107:560-565.
98. Kerr IH, Simon G, Sutton GC: The value of the plain radiograph in acute massive embolism. Br J Radiol 1971;44:751-756.
99. Elliott CG, Goldhaber SZ, Visani L, DeRosa M: Chest radiographs in acute pulmonary embolism. Results from the International Cooperative Pulmonary Embolism Registry. Chest 2000;118:33-38.
100. Levy SE, Simmons DH: Mechanism of arterial hypoxemia following pulmonary thromboembolism in dogs. J Appl Physiol 1975;39:41-46.
101. Wood KE: Major Pulmonary Embolism. Review of a Pathophysiologic Approach to the Golden Hour of Hemodynamically Significant Pulmonary Embolism Chest 2002;121:877-905.
102. D'Alonzo GE, Dantzker DR: Gas exchange alterations following pulmonary thromboembolism. Clin Chest Med 1986;5:411-419.
103. Caldini P: Pulmonary hemodynamics and arterial oxygen saturation in pulmonary embolism. J Appl Physiol 1965;20:184-190.
104. Manier GY, Castaing Y, Guenard GH: Determinants of hypoxemia during acute phase of pulmonary embolism in humans. Am Rev Respir Dis 1985;132:332-338.
105. Dantkzer DR, Wagner PD, Tornabene VW, et al: Gas exchange after pulmonary thromboembolization in dogs. Circ Res 1978;42:92-103.
106. Wilson JE, Pierce AK, Johnson RL: Hypoxemia in pulmonary embolism: A clinical study. J Clin Invest 1971;50:481-491.
107. Moorthy SS, Losasso AM, Gibbs PS: Acquired right to left intracardiac shunt in severe hypoxemia. Crit Care Med 1978;6:28-31.
108. Jardin F, Gurdjian F, Desfonds P, et al: Hemodynamic factors influencing arterial hypoxemia in massive pulmonary embolism with circulatory failure. Circulation 1979;59:909-912.
109. Jehle R, Schlame M, Buttner C, Frey B, Sinha P, Rustow B: Platelet-activating factor (PAF)-acetylhydrolase and PAF-like compounds in the lung: Effects of hyperoxia. Biochim Biophys Acta 2001;1532:60-66.
110. Dantzker DR, Bower JS: Alterations in gas exchange following pulmonary thromboembolism. Chest 1982;81:495-501.
111. Masotti L, Ceccarelli E, Cappelli R, Barabesi L, Forconi S: Arterial blood gas analysis and alveolar-arterial oxygen gradient in diagnosis and prognosis of elderly patients with suspected pulmonary embolism. J Gerontol A Biol Sci Med Sci 2000;55:M761-M764.
112. Benotti JR, Dalen JE: The natural history of pulmonary embolism. Clin Chest Med 1984;5:403-410.
113. Stein M, Levy SE: Reflex and humoral responses to pulmonary embolism. Prog Cardiovasc Dis 1974;17:167-174.
114. Malik AB. Pulmonary microembolism. Physiol Rev 1983;63:1114-1207.
115. Alpert JS, Godtfredsen J, Ockene IS, et al: Pulmonary hypertension secondary to minor pulmonary embolism. Chest 1978;73:795-797.
116. Miller GA, Hall RJ, Paneth M: Pulmonary embolectomy, heparin, and streptokinase: Their place in the treatment of acute massive pulmonary embolism. Am Heart J 1977;93:568-574.
117. Diehl JL, Meyer G, Igual J, et al: Effectiveness and safety of bolus administration of alteplase in massive pulmonary embolism. Am J Cardiol 1992;70:1477-1480.
118. Meneveau N, Schiele F, Metz D, et al: Comparative efficacy of a two-hour regimen of streptokinase versus alteplase in acute massive pulmonary embolism: Immediate clinical and hemodynamic outcome and one-year follow-up. J Am Coll Cardiol 1998;31:1057-1063.
119. Bynum LJ, Wilson JE 3rd: Radiographic features of pleural effusions in pulmonary embolism. Am Rev Respir Dis 1978;117:829-834.
120. Reissig A, Heyne JP, Kroegel C: Sonography of lung and pleura in pulmonary embolism: Sonomorphologic characterization and comparison with spiral CT scanning. Chest 2001;120:1977-1983.
121. Bynum LJ, Wilson JE: Characteristics of pleural effusions associated with pulmonary embolism. Arch Intern Med 1976;136:159-162.
122. Light RW: Pleural effusion due to pulmonary emboli. Curr Opin Pulm Med 2001;7:198-201.
123. Cheng D, Rodriguez RM, Perkett EA, Rogers J, Bienvenu G, Lappalainen U, Light RW: Vascular endothelial growth factor in pleural fluid. Chest 1999;116:760-765.
124. Light RW: Pleural effusion due to pulmonary embolization. Pleural diseases, ed 3. Baltimore, Williams & Wilkins, 1995, pp 187-191.
125. Adelman M, Albelda SM, Gottlieb J, et al: Diagnostic utility of pleural fluid eosinophilia. Am J Med 1984;77:915-920.
126. Downing LJ, Strieter RM, Kadell AM, Austin JC, Hare BD, Burdick MD, Greenfield LJ, Wakefield TW: IL-10 regulates thrombus-induced vein wall inflammation and thrombosis. J Immunol 1998;161:1471-1476.
127. Wakefield TW, Strieter RM, Wilke CA, Kadell AM, Wrobleski SK, Burdick MD, Schmidt R, Kunkel SL, Greenfield LJ: Venous thrombosis-associated inflammation and attenuation with neutralizing antibodies to cytokines and adhesion molecules. Arterioscler Thromb Vasc Biol 1995;15:258-268.
128. Tan P, Luscinskas FW, Homer-Vanniasinkam S: Cellular and molecular mechanisms of inflammation and thrombosis. Eur J Vasc Endovasc Surg 1999;17:373-389.
129. Granger DN, Kubes P: The microcirculation and inflammation: Modulation of leukocyte-endothelial cell adhesion. J Leukoc Biol 1994;55:662-675.
130. Kaplanski G, Marin V, Fabrigoule M, Boulay V, Benoliel A, Bongrano P, Kaplanski S, Farnarier C: Thrombin-activated human endothelial cells support monocyte adhesion in vitro following expression of intercellular adhesion molecule-1 (ICAM-1; CD54) and vascular cell adhesion molecule-1 (VCAM-1; CD106). Blood 1998;92:1259-1267.
131. Sugama Y, Tiruppathi C, Janakidevi K, Andersen TT, Fenton JW, Malik AB: Thrombin-induced expression of endothelial p-selectin and intercellular adhesion molecule-1: A mechanism for stabilizing neutrophil adhesion. J Cell Biol 1992;119:935-944.
132. Wakefield TW, Strieter RM, Schaub R, Myers DD, Prince MR, Wrobleski SK, Londy FJ, Kadell AM, Brown SL, Henke PK, Greenfield LJ: Venous thrombosis prophylaxis by inflammatory inhibition without anticoagulation therapy. J Vasc Surg 2000;31:309-324.
133. Cooper JA, Solano SJ, Bizios R, Kaplan JE, Malik AB: Pulmonary neutrophil kinetics after thrombin-induced intravascular coagulation. J Appl Physiol 1984;57:826-832.
134. Perlman MB, Johnson A, Jubiz W, Malik AB: Lipoxygenase products induce neutrophil activation and increase endothelial permeability after thrombin-induced pulmonary microembolism. Circ Res 1989;64:62-73.
135. Stewart G, Ritchie WG, Lynch PR: Venous endothelial damage produced by massive sticking and emigration of leukocytes. Am J Pathol 1974;74:507-532.
136. Eagleton MJ, Henke PK, Luke CE, Hawley AE, Bedi A, Knipp BS, Wakefield TW, Greenfield LJ: Inflammation and intimal hyperplasia associated with experimental pulmonary embolism. J Vasc Surg 2002;36:581-588.
137. Van Golde LMG, Batenburg JJ, Robertson B: The pulmonary surfactant system. Physiol Rev 1988;68:374-455.
138. Nakos G, Pneumatikos J, Tsangaris H, Telis K, Lekka ME: Protein and phospholipids in BAL from patients with hydrostatic pulmonary edema. Am J Respir Crit Care Med 1997;155:945-951.
139. Hida W, Hildebrandt J: Alveolar surface tension, lung inflation, and hydration effect on interstitial pressure [Px(f)]. J Appl Physiol 1984;57:262-270.
140. Mazzone PJ, Thomassen MJ, Kavuru MS: Pulmonary alveolar proteinosis. Semin Respir Crit Care Med 2002;23:115-126.
141. Wright JR, Dodds LG: Regulation of pulmonary surfactant secretion and clearance. Annu Rev Physiol 1991;53:395-414.
142. Oyarzun MJ, Clements JA: Control of lung surfactant by ventilation, adrenergic mediators and prostaglandins in the rabbit. Am Rev Respir Dis 1978;117:879-891.
143. Kikkawa Y, Smith F: Cellular and biochemical aspects of pulmonary surfactant in health and disease. Lab Invest 1983;49:122-139.
144. Fukahori, M, Murata T, Mohammed MU, Fukuyama N, Nakazawa H: Early reperfusion induces alveolar injury in pulmonary embolism. Chest 1997;111:198-203.
145. Cirino G, Cicala C, Bucci MR, Sorrentino L, Maraganore JM, Stone SR: Thrombin functions as an inflammatory mediator through activation of its receptor. J Exp Med 1996;183:821-827.
146. Bevilacqua MP, Pober JS, Majeau GR, Cotran RS, Gimbrone MA: Interleukin 1 (IL-1) induces biosynthesis and cell surface expression of procoagulant activity in human vascular endothelial cell. J Exp Med 1984;160:618-623.
147. Toosi Z, Sedor JR, Mettler MA, Everson B, Young T, Ratnoff OD: Induction of expression of monocyte interleukin 1 by Hageman factor (factor XII). Proc Natl Acad Sci USA 1992;89:11969-11972.
148. Kroegel C: The potential pathophysiological role of the platelet-activating factor (PAF) in human disease. Klin Wschr 1988;66:373-378.
149. Lorant DE, Patel KDA, McIntyre TM, McEver RP, Prescott SM, Zimmerman GA: Coexpression of GMP-140 and platelet activating factor by endothelium stimulated by histamine and thrombin: A juxtacrine system for adhesion and activation of neurophils. J Cell Biol 1991;115:223-234.
150. Kroegel C, Kortsik C, Kroegel N, Matthys H: The pathophysiological role and therapeutic implications of platelet activating factor in disease of aging. Drugs Aging 1992;2:345-355.
151. Kaplanski G, Fabrigoule M, Boulay V, Dinarello CA, Bongrand P, Farnarier C: Thrombin induces endothelial type II activation in vitro: IL-1 and TNF-independent IL-8 secretion and E-selectin expression. J Immunol 1997;158:5435-5441.
152. Colotta F, Sciacca FL, Sironi M, Luini W, Rabiet MJ, Mantovani A: Expression of monocyte chemotactic protein-1 by monocytes and endothelial cells exposed to thrombin. Am J Pathol 1994;144:975-985.
153. Hanahan DJ: Platelet-activating factor: A biologically active phosphoglyceride. Annu Rev Biochem 1986;55:483-509.
154. Smith CS, Parker L, Shearer WT: Cytokine regulation by platelet-activating factor in a human B cell line. J Immunol 1994;153:3997-4005.
155. Voelkel NF, Stenmark KR, Reeves JT, Mathias MM, Murphy RC: Nonimmunologic production of leukotrienes induced by platelet-activating factor. Science 1982;218:286-288.
156. Lekka ML, Tokumura A, Tsuji H, Hanahan DJ: Isolation of a phospholipid inhibitor of platelet activating factor-induced activity from perfused rat liver: Identification as phosphatidylglycerol. Arch Biochem Biophys 1993;302:380-384.
157. Kroegel C, Foerster M, Häfner D, Grahmann R, Warner JA, Braun R: Putting priming in perspective - From cellular heterogeneity to cellular plasticity. Immunol Today 2000;21:218-222.
158. Tamaoki J, Kondo M, Nakata J, Nagano Y, Isono K, Nagai A: Effect of a thromboxane A antagonist on sputum production and its physicochemical properties in patients with mild to moderate asthma. Chest 2000;118:73-79.
159. Waltham M, Burnand KG, Collins M, Smith A: Vascular endothelial growth factor and basic fibroblast growth factor are found in resolving venous thrombi. J Vasc Surg 2000;32:988-996.
160. Maloney JP, Silliman CC, Ambruso DR, et al: In vitro release of vascular endothelial growth factor during platelet aggregation. Am J Physiol 1998;275:H1054-H1061.
161. Wartiovaara U, Salven P, Mikkola H, et al: Peripheral blood platelets express VEGF-C and VEGF which are released during platelet activation. Thromb Haemost 1998;80:171-175.
162. Henke PK, Wakefield TW, Kadell AM, Linn MJ, Varma MR, Sarkar M, Hawley A, Fowlkes JB, Strieter RM: Interleukin-8 administration enhances venous thrombosis resolution in a rat model. J Surg Res 2001;99:84-91.
163. Downing LJ, Wakefield TW, Strieter RM, Prince MR, Londy FJ, Fowlkes JB, Hulin MS, Kadell AM, Wilke CA, Brown SL, et al: Anti-p-selectin antibody decreases inflammation and thrombus formation in venous thrombosis. J Vasc Surg 1997;25:816-827.
164. Myers DD Jr, Schaub R, Wrobleski SK, Londy FJ 3rd, Fex BA, Chapman AM, Greenfield LJ, Wakefield TW: P-selectin antagonism causes dose-dependent venous thrombosis inhibition. Thromb Haemost 2001;85:423-429.
165. Eppihimer MJ, Schaub RG: P-Selectin-dependent inhibition of thrombosis during venous stasis. Arterioscler Thromb Vasc Biol 2000;20:2483-2488.
166. PIOPED Investigators: Value of the ventilation/perfusion scan in acute pulmonary embolism: Results of the prospective investigation of pulmonary embolism (PIOPED). JAMA 1990;263:2753-2759.
167. Cheriex EC, Sreeram N, Eussen YF, et al: Cross-sectional Doppler echocardiography as the initial technique for diagnosis of acute pulmonary embolism. Br Heart J 1994;72:52-57.
168. Podbregar M, Krivec B, Voga G: Impact of morphologic characteristics of central pulmonary thromboemboli in massive pulmonary embolism. Chest 2002;122:973-979.
169. Corris P, Ellis D, Foley N, et al for the Standards of Care Committee of the British Thoracic Society: Suspected acute pulmonary embolism: A practical approach. Thorax 1997;52(suppl 4):S1-S24.
170. Stein PD, Henry JW: Clinical characteristics of patients with acute pulmonary embolism stratified according to their presenting syndromes. Chest 1997;112:974-979.
171. Cuss FM, Dixon CMS, Barnes PJ: Effects of inhaled platelet activating factor on pulmonary function and bronchial responsiveness in man. Lancet 1986;2:189-192.
172. Taheri SA, Shenoy S, Murawski S, Divan K, Cullin J, Mousa S: Diagnosis of pulmonary embolism by use of urinary TNF-alpha and its soluble TNF receptor I. Angiology 1999;50:703-706.